Genpharmasec holds 34th AGM, reappoints Sohan Chaturvedi as WTD
- Genpharmasec held its 34th AGM via VC on September 29, 2026
- Sohan Chaturvedi reappointed as Whole-Time Director for 3 years
- Audited standalone and consolidated financial statements for FY26 adopted
- Special resolution passed for loans and guarantees under Section 185
*this image is generated using AI for illustrative purposes only.
Genpharmasec Limited held its 34th Annual General Meeting on September 29, 2026, via Video Conferencing. The meeting focused on adopting financial statements for the fiscal year ended March 31, 2026, and securing the reappointment of key leadership.
Sohan Chaturvedi, serving as Whole-Time Director and CFO, was reappointed for a three-year term through a special resolution. He also retired by rotation and was reappointed as a director in his place. The proceedings were conducted in compliance with the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Resolutions passed
The members voted on five key items, covering both ordinary and special business. The audited standalone and consolidated financial statements for FY26 were adopted alongside the Board of Directors' and Auditors' reports.
| Resolution | Type | Description |
|---|---|---|
| 1 | Ordinary | Adopt audited standalone financial statements for FY26 |
| 2 | Ordinary | Adopt audited consolidated financial statements for FY26 |
| 3 | Ordinary | Re-appoint Sohan Chaturvedi as director retiring by rotation |
| 4 | Special | Re-appoint Sohan Chaturvedi as Whole-Time Director for 3 years |
| 5 | Special | Approve loans, guarantees, or security under Section 185 |
Meeting proceedings
The meeting commenced at 11:20 am and concluded at 11:31 am with a vote of thanks. Sohan Chaturvedi chaired the session, confirming that the requisite quorum was present in accordance with Section 103 of the Companies Act, 2013. The Company Secretary briefed members on regulatory matters and general instructions pertaining to e-voting.
Jaymin Modi & Co., Practising Company Secretaries, served as the Scrutinizer to ensure a fair and transparent e-voting process. Voting results pursuant to Regulation 44(3) of the SEBI Listing Regulations will be submitted in due course. The e-voting facility remained open for 15 minutes after the conclusion of proceedings to allow members to cast their votes.
The company confirmed that statutory registers and documents related to ordinary and special business were available for inspection upon request. All notices were sent electronically to members with registered email addresses.
Historical Stock Returns for Genpharmasec
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.88% | -1.75% | +8.74% | +33.33% | -42.56% | -76.22% |
How will the adoption of the FY26 consolidated financial statements impact Genpharmasec's credit rating and borrowing capacity for upcoming expansion projects?
What specific strategic initiatives is Sohan Chaturvedi expected to prioritize during his new three-year term as Whole-Time Director?
What are the intended uses for the loans, guarantees, or securities approved under Section 185, and how might they affect the company's debt-to-equity ratio?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
